Once‐daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing–remitting multiple sclerosis

OBJECTIVE: Multiple sclerosis (MS) prevalence, clinical patterns, and treatment responses vary between races and geographical latitudes. Glatiramer acetate (GA; Copaxone) has provided a safe, effective treatment option for relapsing–remitting MS patients in the USA, European nations, and other count...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamura, Takashi, Ashtamker, Natalia, Ladkani, David, Fukazawa, Toshiyuki, Houzen, Hideki, Tanaka, Masami, Miura, Toshiro, Knappertz, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
MS/NMO and allied disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485168/
https://www.ncbi.nlm.nih.gov/pubmed/28706565
http://dx.doi.org/10.1111/cen3.12383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485168/
https://www.ncbi.nlm.nih.gov/pubmed/28706565
http://dx.doi.org/10.1111/cen3.12383

Ejemplares similares